Loading...
•
Mar 31, 2020
Cassava Sciences Q1 2020 Earnings Report
Reported financial results for the first quarter ended March 31, 2020.
Key Takeaways
Cassava Sciences reported a net loss of $1.2 million, or $0.05 per share, for the first quarter of 2020. Cash and cash equivalents were $25.6 million as of March 31, 2020.
Net loss was $1.2 million, or $0.05 per share.
Net cash used in operations was $1.2 million during the first quarter of 2020.
Cash and cash equivalents were $25.6 million as of March 31, 2020.
Anticipate early data readout for Phase 2b study of PTI-125 in Alzheimer’s Disease.
Forward Guidance
Net cash use in full-year 2020 is expected to be approximately $5 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...